Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study. [electronic resource]
Producer: 20201117Description: 931-940 p. digitalISSN:- 1432-0843
- Area Under Curve
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Monitoring -- methods
- Drug-Related Side Effects and Adverse Reactions -- prevention & control
- Female
- Humans
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- administration & dosage
- Pulse Therapy, Drug -- methods
- Sorafenib -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.